Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vahid Asnafi

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
Blood Advances|January 4, 2018
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemiaLaurent Renou, Pierre-Yves Boelle, Caroline Deswarte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Dynamics of human prothymocytes and xenogeneic thymopoiesis in hematopoietic stem cell-engrafted nonobese diabetic-SCID/IL-2rγnull miceVéronique Parietti, Elisabeth Nelson, Gladys Telliam, et al.
Hemasphere|September 13, 2021
Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and <i>NOTCH1/FBXW7</i> StatusAmélie Trinquand, Adriana Plesa, Chrystelle Abdo, et al.
Nature Communications|March 4, 2025
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancerGuillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, et al.
Haematologica|September 21, 2019
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemiaAurore Touzart, Nicolas Boissel, Mohamed Belhocine, et al.
Blood|June 14, 2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALLGuillaume P Andrieu, Milena Kohn, Mathieu Simonin, et al.
Blood|November 5, 2020
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALLMathieu Simonin, Ludovic Lhermitte, Marie-Emilie Dourthe, et al.
Hematological Oncology|June 30, 2016
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphomaColombe Saillard, Helene Guermouche, Coralie Derrieux, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Blood Advances|January 4, 2018
Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemiaLaurent Renou, Pierre-Yves Boelle, Caroline Deswarte, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Dynamics of human prothymocytes and xenogeneic thymopoiesis in hematopoietic stem cell-engrafted nonobese diabetic-SCID/IL-2rγnull miceVéronique Parietti, Elisabeth Nelson, Gladys Telliam, et al.
Hemasphere|September 13, 2021
Toward Pediatric T Lymphoblastic Lymphoma Stratification Based on Minimal Disseminated Disease and <i>NOTCH1/FBXW7</i> StatusAmélie Trinquand, Adriana Plesa, Chrystelle Abdo, et al.
Nature Communications|March 4, 2025
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancerGuillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, et al.
Haematologica|September 21, 2019
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemiaAurore Touzart, Nicolas Boissel, Mohamed Belhocine, et al.
Blood|June 14, 2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALLGuillaume P Andrieu, Milena Kohn, Mathieu Simonin, et al.
Blood|November 5, 2020
IKZF1 alterations predict poor prognosis in adult and pediatric T-ALLMathieu Simonin, Ludovic Lhermitte, Marie-Emilie Dourthe, et al.
Hematological Oncology|June 30, 2016
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphomaColombe Saillard, Helene Guermouche, Coralie Derrieux, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Pageof 18